Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Jin Yang Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,119	2,204	1,780	5,118	753.56	11,720
Short-Term Investments	3,000	-	-	2,600	7,890	120
Trading Asset Securities	3,172	3,684	233.78	877.27	1,851	3,035
Cash & Short-Term Investments	7,291	5,888	2,013	8,595	10,494	14,875
Cash Growth	173.70%	192.43%	-76.58%	-18.09%	-29.45%	179.33%
Accounts Receivable	24,725	23,065	26,098	21,711	19,885	16,670
Other Receivables	12.18	80.84	399.99	76.11	63.14	42.37
Receivables	25,537	23,445	26,498	21,788	20,248	17,012
Inventory	14,800	15,622	14,623	17,353	15,423	9,060
Prepaid Expenses	40.67	48.31	57.15	44.01	42.83	35.76
Other Current Assets	51.83	1,021	162.97	248.99	120.07	21.97
Total Current Assets	47,720	46,024	43,355	48,029	46,329	41,005
Property, Plant & Equipment	47,654	47,664	43,494	44,136	43,794	39,363
Long-Term Investments	3,872	1,774	1,243	3,087	4,279	4,238
Other Intangible Assets	6,159	6,537	5,043	4,886	3,573	1,870
Long-Term Accounts Receivable	-	-	-	-	0	-0
Long-Term Deferred Charges	916.66	848.88	1,188	1,630	1,407	-
Other Long-Term Assets	167,944	164,814	132,951	17,838	15,062	12,025
Total Assets	274,418	267,809	227,574	119,907	114,444	98,502

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,658	3,028	4,206	2,444	2,536	265.09
Accrued Expenses	3,237	2,571	2,534	2,554	2,245	2,061
Short-Term Debt	75,569	1,120	2,781	7,525	19,530	19,822
Current Portion of Long-Term Debt	-	75,300	1,200	-	-	-
Current Portion of Leases	270.82	195.31	221.68	207.76	198.45	113.92
Current Income Taxes Payable	601.54	-	998.77	1,374	1,442	678.45
Current Unearned Revenue	152.16	79.64	13.96	8.9	11.93	53.21
Other Current Liabilities	9,298	5,784	7,838	10,398	4,974	4,149
Total Current Liabilities	91,786	88,078	19,794	24,511	30,938	27,143
Long-Term Debt	-	-	75,300	-	-	-
Long-Term Leases	201.01	141.32	179.24	98.45	253.46	76.7
Pension & Post-Retirement Benefits	-	-	620.19	431.1	302.76	-
Long-Term Deferred Tax Liabilities	17,236	17,073	9,707	4,550	4,757	3,688
Other Long-Term Liabilities	3,036	2,659	2,096	1,558	618	2,277
Total Liabilities	112,259	107,952	107,696	31,149	36,869	33,184

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	7,067	7,067	6,326	6,008	6,000	6,000
Additional Paid-In Capital	23,142	23,142	13,366	9,737	9,625	9,625
Retained Earnings	111,868	109,566	88,666	61,323	51,884	40,626
Treasury Stock	-	-	-5,643	-5,643	-5,643	-3,069
Comprehensive Income & Other	20,081	20,081	17,164	17,333	15,709	12,136
Shareholders' Equity	162,159	159,857	119,878	88,758	77,575	65,318
Total Liabilities & Equity	274,418	267,809	227,574	119,907	114,444	98,502

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	76,040	76,757	79,682	7,831	19,982	20,013
Net Cash (Debt)	-68,750	-70,869	-77,668	764.1	-9,488	-5,138
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-5690.03	-6298.40	61.24	-705.79	-450.13
Filing Date Shares Outstanding	-	14.13	11.43	10.79	10.78	11.18
Total Common Shares Outstanding	-	14.13	11.43	10.79	10.78	11.18
Working Capital	-44,066	-42,054	23,561	23,518	15,391	13,862
Book Value Per Share	-	11309.62	10490.95	8224.03	7199.14	5843.71
Tangible Book Value	156,000	153,320	114,834	83,871	74,002	63,448
Tangible Book Value Per Share	-	10847.15	10049.58	7771.28	6867.59	5676.41
Land	31,678	31,652	27,366	26,901	23,983	19,589
Buildings	18,937	18,937	18,906	18,906	18,906	18,906
Machinery	21,542	21,025	19,700	19,272	18,782	19,455
Construction In Progress	99	17.2	86.6	32	1,157	448.88

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error